Ultramicrosize Griseofulvin (CorePharma, LLC)
Welcome to the PulseAid listing for the Ultramicrosize Griseofulvin drug offered from CorePharma, LLC. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | CorePharma, LLC |
NON-PROPRIETARY NAME: | Ultramicrosize Griseofulvin Tablets |
SUBSTANCE NAME: | GRISEOFULVIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-09-29 |
END MARKETING DATE: | 0000-00-00 |
Ultramicrosize Griseofulvin HUMAN PRESCRIPTION DRUG Details:
Item Description | Ultramicrosize Griseofulvin from CorePharma, LLC |
LABELER NAME: | CorePharma, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/1) |
START MARKETING DATE: | 2014-09-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64720-295_c4bbdcaf-f7d6-4f94-89f4-776cf643fdbc |
PRODUCT NDC: | 64720-295 |
APPLICATION NUMBER: | ANDA204371 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers: